TfR2ヘテロ接合型変異で発症したヘモクロマトーシスの1例

症例は38歳,男性.肝機能障害にて当科を受診し,血液検査で肝酵素の上昇に加え,血清鉄,フェリチンの上昇を認めた.肝生検組織の鉄染色で肝細胞に鉄沈着を認めた.輸血や鉄剤での治療の既往はなく,HFE,HJV,HAMP,TfR2,SLC40A1の鉄代謝関連遺伝子検査を行い,TfR2のヘテロ接合型変異(c.1206c>M)を認めた.以上の結果からtype3遺伝性ヘモクロマトーシスと診断し,食生活の変更とともに定期的な瀉血療法を行ったところ,血清フェリチンは正常化し,肝機能は改善した.TfR2の変異による遺伝性ヘモクロマトーシスは常染色体劣性遺伝であり,通常はホモ接合型で発症する.本症例はTfR2のヘテ...

Full description

Saved in:
Bibliographic Details
Published in肝臓 Vol. 63; no. 3; pp. 151 - 157
Main Authors 原田, 大, 森野, 加帆里, 巽, 康彰, 林, 久男, 柴田, 道彦, 熊元, 啓一郎, 生田, 克哉, 宮川恒, 一郎, 土岐, 康通, 阿部, 慎太郎, 本間, 雄一, 大江, 晋司, 西尾, 仁
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本肝臓学会 01.03.2022
Subjects
Online AccessGet full text
ISSN0451-4203
1881-3593
DOI10.2957/kanzo.63.151

Cover

Abstract 症例は38歳,男性.肝機能障害にて当科を受診し,血液検査で肝酵素の上昇に加え,血清鉄,フェリチンの上昇を認めた.肝生検組織の鉄染色で肝細胞に鉄沈着を認めた.輸血や鉄剤での治療の既往はなく,HFE,HJV,HAMP,TfR2,SLC40A1の鉄代謝関連遺伝子検査を行い,TfR2のヘテロ接合型変異(c.1206c>M)を認めた.以上の結果からtype3遺伝性ヘモクロマトーシスと診断し,食生活の変更とともに定期的な瀉血療法を行ったところ,血清フェリチンは正常化し,肝機能は改善した.TfR2の変異による遺伝性ヘモクロマトーシスは常染色体劣性遺伝であり,通常はホモ接合型で発症する.本症例はTfR2のヘテロ接合型変異であったが,肉類の摂取量が多く,生活習慣が発症に寄与した可能性が示唆され,瀉血療法に加えて生活習慣の変更が鉄過剰の改善に有効であった.
AbstractList 症例は38歳,男性.肝機能障害にて当科を受診し,血液検査で肝酵素の上昇に加え,血清鉄,フェリチンの上昇を認めた.肝生検組織の鉄染色で肝細胞に鉄沈着を認めた.輸血や鉄剤での治療の既往はなく,HFE,HJV,HAMP,TfR2,SLC40A1の鉄代謝関連遺伝子検査を行い,TfR2のヘテロ接合型変異(c.1206c>M)を認めた.以上の結果からtype3遺伝性ヘモクロマトーシスと診断し,食生活の変更とともに定期的な瀉血療法を行ったところ,血清フェリチンは正常化し,肝機能は改善した.TfR2の変異による遺伝性ヘモクロマトーシスは常染色体劣性遺伝であり,通常はホモ接合型で発症する.本症例はTfR2のヘテロ接合型変異であったが,肉類の摂取量が多く,生活習慣が発症に寄与した可能性が示唆され,瀉血療法に加えて生活習慣の変更が鉄過剰の改善に有効であった.
Author 森野, 加帆里
阿部, 慎太郎
生田, 克哉
原田, 大
宮川恒, 一郎
土岐, 康通
柴田, 道彦
西尾, 仁
熊元, 啓一郎
大江, 晋司
巽, 康彰
本間, 雄一
林, 久男
Author_xml – sequence: 1
  fullname: 原田, 大
  organization: 産業医科大学第3内科学
– sequence: 1
  fullname: 森野, 加帆里
  organization: 産業医科大学第3内科学
– sequence: 1
  fullname: 巽, 康彰
  organization: 愛知学院大学薬物治療学
– sequence: 1
  fullname: 林, 久男
  organization: 愛知学院大学薬物治療学
– sequence: 1
  fullname: 柴田, 道彦
  organization: 産業医科大学第3内科学
– sequence: 1
  fullname: 熊元, 啓一郎
  organization: 産業医科大学第2病理学
– sequence: 1
  fullname: 生田, 克哉
  organization: 北海道赤十字血液センター
– sequence: 1
  fullname: 宮川恒, 一郎
  organization: 産業医科大学第3内科学
– sequence: 1
  fullname: 土岐, 康通
  organization: 旭川医科大学消化器・血液腫瘍制御内科学
– sequence: 1
  fullname: 阿部, 慎太郎
  organization: 産業医科大学第3内科学
– sequence: 1
  fullname: 本間, 雄一
  organization: 産業医科大学第3内科学
– sequence: 1
  fullname: 大江, 晋司
  organization: 産業医科大学第3内科学
– sequence: 1
  fullname: 西尾, 仁
  organization: 産業医科大学第3内科学
BookMark eNo9kMtKw0AYhQepYKzd-Rqp_8wkk5mVSPEGFUHqOkwmGW2trSTd6C4NaKUgbqS6qSCKKy87UcSXGWNfw1rFzTmL83EW3ywqtNqtCKF5DGUiXG9hT7aO2mVGy9jFU8jCnGObuoIWkAWOi22HAJ1BpSSpBwCEeSAEsdBGTW8Rk12a7NhkD19nd_l5Lx_289vT0cWzSe9HV2-jwYlJBya9nmA3pvs0Jk02NFnPZO-m-2K6ryZ9xJ8f_Tk0rWUziUp_XUTbK8u1yppd3VxdryxV7QbxCNhU61CEgVYQCiWJJCxQhOiQOFRRrLEHVLuYK-I5UQhKcCaAg3Q5hZAx4LSIFn9_G0lH7kT-QVzfl_GhL-NOXTUjf-LCZ9SnPzEW8r-oXRn7DUm_ASidc_Y
ContentType Journal Article
Copyright 2022 一般社団法人 日本肝臓学会
Copyright_xml – notice: 2022 一般社団法人 日本肝臓学会
DOI 10.2957/kanzo.63.151
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1881-3593
EndPage 157
ExternalDocumentID article_kanzo_63_3_63_151_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
CS3
JSF
KQ8
OK1
P2P
RJT
ID FETCH-LOGICAL-j2720-3ffd9dbfc0d9ca2a26bc22fd243c31f1703f518c274ed0c9869080a5830d66083
ISSN 0451-4203
IngestDate Wed Sep 03 06:30:40 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2720-3ffd9dbfc0d9ca2a26bc22fd243c31f1703f518c274ed0c9869080a5830d66083
OpenAccessLink https://www.jstage.jst.go.jp/article/kanzo/63/3/63_151/_article/-char/ja
PageCount 7
ParticipantIDs jstage_primary_article_kanzo_63_3_63_151_article_char_ja
PublicationCentury 2000
PublicationDate 20220300
PublicationDateYYYYMMDD 2022-03-01
PublicationDate_xml – month: 03
  year: 2022
  text: 20220300
PublicationDecade 2020
PublicationTitle 肝臓
PublicationTitleAlternate 肝臓
PublicationYear 2022
Publisher 一般社団法人 日本肝臓学会
Publisher_xml – name: 一般社団法人 日本肝臓学会
References 21) Hino K, Nishina S, Hara Y. Iron metabolic disorder in chronic hepatitis C: mechanisms and relevance to hepatocarcinogenesis. J Gastroenterol Hepatol 2013; 28 Suppl 4: 93-98
1) Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet 2016; 388: 706-716
5) Hayashi H, Wakusawa S, Motonishi S, et al. Genetic background of primary iron overload syndromes in Japan. Intern Med 2006; 45: 1107-1111
16) Koyama C, Wakusawa S, Hayashi H, et al. Two novel mutations, L490R and V561X, in the transferrin receptor 2 in Japanese patients with hemochromatosis. Haematologica 2005; 90: 302-307
18) Majore S, Ricerca BM, Radio FC, et al. Type 3 hereditary hemochromatosis in a patient from sub-Saharan Africa: is there a link between African iron overload and TFR2 dysfunction? Blood Cells Mol Dis 2013; 50: 31-32
12) De Domenico I, Ward DM, Musci G, et al. Iron overload due to mutations in ferroportin. Haematologica 2006; 91: 92-95
15) Hattori A, Wakusawa S, Hayashi H, et al. AVAQ 594-597 deletion of the TfR2 gene in a Japanese family with hemochromatosis. Hepatol Res 2003; 26: 154-156
19) Fujihara J, Yasuda T, Kimura-Kataoka K, et al. Association of SNPs in transferrin and transferrin receptor genes with blood iron levels in human. Leg Med (Tokyo) 2019; 36: 17-20
11) Hollerer I, Bachmann A, Muckenthaler MU. Pathophysiological consequences and benefits of HFE mutations: 20 years of research. Haematologica 2017; 102: 809-817
6) Hayashi H, Yano M, Urawa N, et al. A 10-year follow-up study of a Japanese family with ferroportin disease A: mild iron overload with mild hyperferritinemia co-occurring with hyperhepcidinemia may be benign. Intern Med 2018; 57: 2865-2871
13) Bardou-Jacquet E, Ben Ali Z, Beaumont-Epinette MP, et al. Non-HFE hemochromatosis: pathophysiological and diagnostic aspects. Clin Res Hepatol Gastroenterol 2014; 38: 143-154
20) Pichler I, Minelli C, Sanna S, et al. Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels. Hum Mol Genet 2011; 20: 1232-1240
3) Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 2010; 139: 393-408
10) Barton JC, Edwards CQ, Acton RT. HFE gene: Structure, function, mutations, and associated iron abnormalities. Gene 2015; 574: 179-192
4) Bomford A. Genetics of haemochromatosis. Lancet 2002; 360: 1673-1681
14) 土田健一, 種田紳二, 三澤和史, 他. 糖尿病, 下垂体性腺機能低下症, 肝線維化を呈した新規TfR2遺伝子変異による原発性ヘモクロマトーシス (HH Type3) の1例. 糖尿病 2010; 53: 247-252
7) Kawabata H, Yang R, Hirama T, et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 1999; 274: 20826-20832
2) Ikuta K, Hatayama M, Addo L, et al. Iron overload patients with unknown etiology from national survey in Japan. Int J Hematol 2017; 105: 353-360
9) Girelli D, Trombini P, Busti F, et al. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis. Haematologica 2011; 96: 500-506
17) Kawaguchi T, Ikuta K, Tatsumi Y, et al. Identification of heterozygous p.T150C and p.V274M mutations in HJV gene in a Japanese patient with mild phenotype of juvenile hemochromatosis: A case report. Hepatol Res 2019; 50: 144-150
8) Radio FC, Majore S, Binni F, et al. TFR2-related hereditary hemochromatosis as a frequent cause of primary iron overload in patients from Central-Southern Italy. Blood Cells Mol Dis 2014; 52: 83-87
References_xml – reference: 12) De Domenico I, Ward DM, Musci G, et al. Iron overload due to mutations in ferroportin. Haematologica 2006; 91: 92-95
– reference: 14) 土田健一, 種田紳二, 三澤和史, 他. 糖尿病, 下垂体性腺機能低下症, 肝線維化を呈した新規TfR2遺伝子変異による原発性ヘモクロマトーシス (HH Type3) の1例. 糖尿病 2010; 53: 247-252
– reference: 21) Hino K, Nishina S, Hara Y. Iron metabolic disorder in chronic hepatitis C: mechanisms and relevance to hepatocarcinogenesis. J Gastroenterol Hepatol 2013; 28 Suppl 4: 93-98
– reference: 17) Kawaguchi T, Ikuta K, Tatsumi Y, et al. Identification of heterozygous p.T150C and p.V274M mutations in HJV gene in a Japanese patient with mild phenotype of juvenile hemochromatosis: A case report. Hepatol Res 2019; 50: 144-150
– reference: 5) Hayashi H, Wakusawa S, Motonishi S, et al. Genetic background of primary iron overload syndromes in Japan. Intern Med 2006; 45: 1107-1111
– reference: 11) Hollerer I, Bachmann A, Muckenthaler MU. Pathophysiological consequences and benefits of HFE mutations: 20 years of research. Haematologica 2017; 102: 809-817
– reference: 19) Fujihara J, Yasuda T, Kimura-Kataoka K, et al. Association of SNPs in transferrin and transferrin receptor genes with blood iron levels in human. Leg Med (Tokyo) 2019; 36: 17-20
– reference: 20) Pichler I, Minelli C, Sanna S, et al. Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels. Hum Mol Genet 2011; 20: 1232-1240
– reference: 4) Bomford A. Genetics of haemochromatosis. Lancet 2002; 360: 1673-1681
– reference: 6) Hayashi H, Yano M, Urawa N, et al. A 10-year follow-up study of a Japanese family with ferroportin disease A: mild iron overload with mild hyperferritinemia co-occurring with hyperhepcidinemia may be benign. Intern Med 2018; 57: 2865-2871
– reference: 10) Barton JC, Edwards CQ, Acton RT. HFE gene: Structure, function, mutations, and associated iron abnormalities. Gene 2015; 574: 179-192
– reference: 18) Majore S, Ricerca BM, Radio FC, et al. Type 3 hereditary hemochromatosis in a patient from sub-Saharan Africa: is there a link between African iron overload and TFR2 dysfunction? Blood Cells Mol Dis 2013; 50: 31-32
– reference: 13) Bardou-Jacquet E, Ben Ali Z, Beaumont-Epinette MP, et al. Non-HFE hemochromatosis: pathophysiological and diagnostic aspects. Clin Res Hepatol Gastroenterol 2014; 38: 143-154
– reference: 15) Hattori A, Wakusawa S, Hayashi H, et al. AVAQ 594-597 deletion of the TfR2 gene in a Japanese family with hemochromatosis. Hepatol Res 2003; 26: 154-156
– reference: 1) Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet 2016; 388: 706-716
– reference: 9) Girelli D, Trombini P, Busti F, et al. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis. Haematologica 2011; 96: 500-506
– reference: 7) Kawabata H, Yang R, Hirama T, et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 1999; 274: 20826-20832
– reference: 8) Radio FC, Majore S, Binni F, et al. TFR2-related hereditary hemochromatosis as a frequent cause of primary iron overload in patients from Central-Southern Italy. Blood Cells Mol Dis 2014; 52: 83-87
– reference: 2) Ikuta K, Hatayama M, Addo L, et al. Iron overload patients with unknown etiology from national survey in Japan. Int J Hematol 2017; 105: 353-360
– reference: 3) Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 2010; 139: 393-408
– reference: 16) Koyama C, Wakusawa S, Hayashi H, et al. Two novel mutations, L490R and V561X, in the transferrin receptor 2 in Japanese patients with hemochromatosis. Haematologica 2005; 90: 302-307
SSID ssib002670992
ssib000940394
ssib002670224
ssib058493441
ssj0069113
ssib005879686
ssib002484534
Score 2.2944317
Snippet ...
SourceID jstage
SourceType Publisher
StartPage 151
SubjectTerms TfR2
ヘテロ接合型変異
ヘモクロマトーシス
生活習慣
遺伝性
Title TfR2ヘテロ接合型変異で発症したヘモクロマトーシスの1例
URI https://www.jstage.jst.go.jp/article/kanzo/63/3/63_151/_article/-char/ja
Volume 63
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 肝臓, 2022/03/01, Vol.63(3), pp.151-157
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9VAMNQK4kX8xG96cI-vJtmP7B4376UUpYLSQm8hn-AT2iLtxdt7D7RSEC9SvVQQxZMfN1HEH-DfiM_-DWc2m9e09FB7CZPNzO58JJmZzezGcW6JUnG3EJCpcuV2WO6n8B4ssg4VZVL6PCmZh2uHF-6J-SV2Z5kvT5343apa2lhPZ7Mnh64rOY5VoQ3siqtk_8Oyk06hAWCwLxzBwnA8mo3LBz6JKJGUKGkBKSygeyQSREZEcxJxolwipQEiIkMENISRikQBUZyErqHyiA5MiyKhNkBAZGAvqQkwd3BQXbPhEz3XGr3GiRrGGuSwa5HDoAFUM3rkkYiREFlsh80kkoinegYAtiZvKxQEZESWoJmhIHDTWPF0sIcmiAaugBmFHcioQZOaaBeBUBrd1Ze77f6Bz7DX4INekG-OTaHb7h8kxf2GEY2hSJI3PAXtuRVIyyfFZeZpMOgSS05QOEl0F-m0UQPaK0TOof-QoqUQWRvrUCRBKoHjopUB6Bryg9oy-ugRLQx5lyjdcgCMQ37vu7VKi9pBSel1KLdqth7MuoiH7QkO4448u5lvYc-Cw5ymr8yfnh9BLrI6K-jshGjfNuT2Jo8NWixoTPEAuHFzBZcJxn3IVU76QWBKJu7eb4X6irm0PZXAJOO0PRUQYDi571y1vvhzGSixt9UhxM2KmlC-jroEOG1TTdLorF7kgrLdbksGgWYf0q6mZNNEkYtnnTM2_ZvRtTDnnKl-ct45tWALXC44C_hIV6PX1ehpNfr098WH8cvN8c7W-P3z3Vdfq8HH3Tc_drefVYPtavDWoL2rhl8AsxrtVKPNavSzGn6rht-rwWfvz6-ti87SXLTYne_YP550-lgP0aFlmas8LTM3V1niJ75IM98vc5_RjHqlB-655J7M_IAVuZsp_J2cdBMuqZsLAdnUJWd6ZXWluOzM8DyTXkFpmijGcsZTiPWTArqGDIgnXF1xZK2IeK3e1iY-soWvHp_0mnN67zm77kyvP94obkBUv57eNLfLPxRgxtQ
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TfR2%E3%83%98%E3%83%86%E3%83%AD%E6%8E%A5%E5%90%88%E5%9E%8B%E5%A4%89%E7%95%B0%E3%81%A7%E7%99%BA%E7%97%87%E3%81%97%E3%81%9F%E3%83%98%E3%83%A2%E3%82%AF%E3%83%AD%E3%83%9E%E3%83%88%E3%83%BC%E3%82%B7%E3%82%B9%E3%81%AE1%E4%BE%8B&rft.jtitle=%E8%82%9D%E8%87%93&rft.au=%E5%8E%9F%E7%94%B0%2C+%E5%A4%A7&rft.au=%E6%A3%AE%E9%87%8E%2C+%E5%8A%A0%E5%B8%86%E9%87%8C&rft.au=%E5%B7%BD%2C+%E5%BA%B7%E5%BD%B0&rft.au=%E6%9E%97%2C+%E4%B9%85%E7%94%B7&rft.date=2022-03-01&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA%E3%80%80%E6%97%A5%E6%9C%AC%E8%82%9D%E8%87%93%E5%AD%A6%E4%BC%9A&rft.issn=0451-4203&rft.eissn=1881-3593&rft.volume=63&rft.issue=3&rft.spage=151&rft.epage=157&rft_id=info:doi/10.2957%2Fkanzo.63.151&rft.externalDocID=article_kanzo_63_3_63_151_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0451-4203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0451-4203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0451-4203&client=summon